Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Ligands. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110452150B discloses a novel organocatalytic route for high-purity axial chiral indole-naphthalenes. This method offers significant cost reduction in chiral catalyst manufacturing and scalable production capabilities.
High-yield, high-ee synthesis of non-natural amino acids with water as proton source. Reduce production costs and supply chain risks for API manufacturing.
Solve chiral ligand supply chain risks with this metal-free synthesis. 86% yield, no resolution needed. Contact for custom production.
Solve asymmetric synthesis challenges with novel chiral nitrogen-diene ligands. 99% yield, 90% ee, and water-tolerant processes reduce production costs for pharma R&D and manufacturing.
Solve asymmetric synthesis challenges with novel chiral nitrogen-diene ligands. 99% yield, 90% ee in rhodium-catalyzed reactions. Scale to 100 MT/annual with NINGBO INNO PHARMCHEM.
Eliminate chiral column costs with novel crystallization-based resolution. Achieve >99% ee and 76-78% yield for 6,6'-dihydroxy-5,5'-bisquinoline. Scale to 100MT/yr with NINGBO INNO PHARMCHEM's CDMO expertise.
Discover how visible light-driven catalysis enables 80-90% yields with 90-99% ee for chiral alpha-unnatural amino acids, eliminating costly chiral resolution steps in drug development.
Discover how visible light-driven copper catalysis eliminates chiral resolution steps, achieves 90-99% ee, and reduces production costs for non-natural amino acid derivatives in pharmaceutical synthesis.
Struggling with high-temperature, toxic solvent processes for 9-acetoxy-9,10-dihydrophenanthrene? Discover emerging iridium photocatalysis for green, high-yield synthesis. Find reliable suppliers now.